Zurich Cantonal Bank Portfolio holdings
AUM
$40.9B
1-Year Return
22.88%
This Quarter Return
-13.13%
1 Year Return
+22.88%
3 Year Return
+106.76%
5 Year Return
+189.8%
10 Year Return
+428.78%
AUM
$9.94B
AUM Growth
-$1.84B
(-16%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
20.27%
Holding
2,652
New
67
Increased
901
Reduced
495
Closed
58
Top Buys
| 1 |
UBS Group
UBS
|
+$44.1M |
| 2 |
Linde
LIN
|
+$42M |
| 3 |
Verizon
VZ
|
+$20.5M |
| 4 |
Alibaba
BABA
|
+$18.9M |
| 5 |
Merck
MRK
|
+$17.5M |
Top Sells
| 1 |
PX
Praxair Inc
PX
|
+$28.3M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$25.3M |
| 3 |
Eastman Chemical
EMN
|
+$19.9M |
| 4 |
Cisco
CSCO
|
+$17.1M |
| 5 |
AET
Aetna Inc
AET
|
+$14.5M |
Sector Composition
| 1 | Financials | 19.19% |
| 2 | Technology | 16.63% |
| 3 | Healthcare | 13.76% |
| 4 | Consumer Discretionary | 9.6% |
| 5 | Communication Services | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
BJ's Restaurants
BJRI
$716M
| $80K | ﹤0.01% |
1,578
+357
| +29% | +$18.1K |
|
1727
US Physical Therapy
USPH
$1.25B
| $80K | ﹤0.01% |
779
| – | – |
|
|
PTLA
1728
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $80K | ﹤0.01% |
4,098
| – | – |
|
1729
AB InBev
BUD
$115B
| $79K | ﹤0.01% |
1,200
+600
| +100% | +$39.5K |
|
1730
Nelnet
NNI
$4.51B
| $79K | ﹤0.01% |
1,517
+375
| +33% | +$19.5K |
|
|
VRTU
1731
DELISTED
Virtusa Corporation
VRTU
| $79K | ﹤0.01% |
1,862
+603
| +48% | +$25.6K |
|
|
AYR
1732
DELISTED
Aircastle Limited
AYR
| $79K | ﹤0.01% |
4,560
+1,048
| +30% | +$18.2K |
|
|
TAHO
1733
DELISTED
Tahoe Resources Inc
TAHO
| $79K | ﹤0.01% |
21,695
+5,886
| +37% | +$21.4K |
|
1734
Arcosa
ACA
$4.81B
| $78K | ﹤0.01% |
+2,812
| New | +$78K |
|
|
ALEX
1735
Alexander & Baldwin
ALEX
$1.37B
| $78K | ﹤0.01% |
4,253
| – | – |
|
1736
Corcept Therapeutics
CORT
$7.83B
| $78K | ﹤0.01% |
5,862
| – | – |
|
1737
Cavco Industries
CVCO
$4.39B
| $78K | ﹤0.01% |
600
| – | – |
|
1738
Evolent Health
EVH
$1.08B
| $78K | ﹤0.01% |
3,913
| – | – |
|
1739
G-III Apparel Group
GIII
$1.15B
| $78K | ﹤0.01% |
2,795
+461
| +20% | +$12.9K |
|
1740
Gray Television
GTN
$599M
| $78K | ﹤0.01% |
5,316
+1,248
| +31% | +$18.3K |
|
1741
IMAX
IMAX
$1.71B
| $78K | ﹤0.01% |
4,125
| – | – |
|
1742
Kulicke & Soffa
KLIC
$2.03B
| $78K | ﹤0.01% |
3,824
| – | – |
|
1743
Medpace
MEDP
$14B
| $78K | ﹤0.01% |
1,483
| – | – |
|
1744
Intellia Therapeutics
NTLA
$1.23B
| $78K | ﹤0.01% |
5,733
| – | – |
|
1745
Sangamo Therapeutics
SGMO
$160M
| $78K | ﹤0.01% |
6,787
+1,552
| +30% | +$17.8K |
|
|
MTOR
1746
DELISTED
MERITOR, Inc.
MTOR
| $78K | ﹤0.01% |
4,638
| – | – |
|
|
QEP
1747
DELISTED
QEP RESOURCES, INC.
QEP
| $78K | ﹤0.01% |
13,922
| – | – |
|
1748
CTS Corp
CTS
$1.26B
| $77K | ﹤0.01% |
2,963
| – | – |
|
1749
Pitney Bowes
PBI
$1.97B
| $77K | ﹤0.01% |
13,077
+3,170
| +32% | +$18.7K |
|
1750
Rio Tinto
RIO
$102B
| $77K | ﹤0.01% |
1,597
-300
| -16% | -$14.5K |
|